Family Smoking Prevention and Tobacco Control Act

The Family Smoking Prevention and Tobacco Control Act is a United States federal law that was enacted on June 22, 2009. The law gives the Food and Drug Administration (FDA) the authority to regulate the manufacture, distribution, and marketing of tobacco products to protect public health.
Background[edit]
The act was signed into law by President Barack Obama, who himself was a former smoker. The legislation was a significant step in the ongoing efforts to reduce tobacco use and its associated health risks in the United States. Prior to this act, the FDA had limited authority over tobacco products.
Key Provisions[edit]
The Family Smoking Prevention and Tobacco Control Act includes several key provisions aimed at reducing tobacco use, particularly among youth:
- **Regulation of Ingredients**: The FDA has the authority to regulate the ingredients in tobacco products, including the reduction or elimination of harmful substances.
- **Ban on Flavored Cigarettes**: The act bans the sale of flavored cigarettes, which are particularly appealing to young people.
- **Graphic Warning Labels**: Tobacco product packaging and advertisements must include graphic warning labels to inform consumers about the health risks of smoking.
- **Advertising Restrictions**: The act imposes restrictions on tobacco advertising, particularly those targeting youth. This includes a ban on the use of terms like "light," "mild," and "low-tar."
- **Pre-market Review**: New tobacco products must undergo a pre-market review by the FDA before they can be sold.
- **Tobacco Product Standards**: The FDA can set standards for tobacco products to protect public health, including the reduction of nicotine levels.
Impact[edit]
Since its enactment, the Family Smoking Prevention and Tobacco Control Act has had a significant impact on public health. The regulation of tobacco products has led to a decrease in smoking rates, particularly among youth. The graphic warning labels and advertising restrictions have also contributed to increased awareness of the dangers of smoking.
Criticism and Challenges[edit]
Despite its successes, the act has faced criticism and legal challenges. Some argue that the restrictions on advertising infringe on First Amendment rights. Others believe that the FDA's regulatory authority over tobacco products should be expanded further to include other nicotine delivery systems, such as e-cigarettes.
See Also[edit]
- Tobacco Master Settlement Agreement
- Public health
- Nicotine addiction
- Smoking cessation
- Youth smoking
References[edit]
External Links[edit]
| Health care | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian